Adaptimmune Therapeutics PLC
ADAPY· OTC
ADAPYAdaptimmune Therapeutics PLC
Filed Nov 10, 2016 · 10-Q · 41 days after period end · 0001104659-16-156035
| Metric | Q3 2016 | Q3 2015 |
|---|---|---|
| Revenue | $2.42M | $4.95M |
| Net Income | -$18.49M | -$6.24M |
| EPS Diluted | -$0.04 | -$0.01 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Adaptimmune Therapeutics PLC · CIK 1621227 · Engraved from SEC EDGAR
ended Sep 30, 2016 · filed Nov 10, 2016 · 41 d after period end
